How do you ensure, for a GMP new build or retrofit, that the first regulatory inspection is passed and that the first commercial batch can be released on schedule?
We integrate the entire CQV programme (Commissioning, Qualification and Validation) into the construction project plan from the planning phase onwards - not as a downstream quality check, but as a parallel process stream. Entourage brings qualified CQV expertise directly into your project team and connects Engineering, QA and Regulatory so that FATs and SATs already serve as an IQ basis, deviations are tracked in a shared register across all trades, and the qualification package is complete when construction finishes. The decisive step happens before the first sod is turned: anyone who defines acceptance criteria only after equipment has been ordered is performing a documentation exercise. EU GMP Annex 15, the ISPE Baseline Guide and PIC/S PI 006-3 set the framework within which qualification activities are linked to the project plan.
- Pharma
- Biotech
Overview
Why do CQV programmes fail in practice?
CQV programmes across sterile fill-finish, biotech API and OSD facilities in EU- and FDA-regulated environments
Last updated: 2026-06-18
Delivering a GMP new build on time and on budget is hard enough. Steering it through regulatory qualification while simultaneously coordinating dozens of trades, suppliers and internal stakeholders is the point at which programmes collapse. Four patterns recur across projects:
- No unified qualification strategy: multiple trades and suppliers work without a shared documentation framework and without aligned acceptance criteria. Every contractor defines 'qualified' according to its own logic, with no reference to the shared qualification package.
- Decoupled engineering and QA documentation: FAT and SAT records are not aligned with IQ/OQ/PQ protocols. This forces redundant test runs and delays release, because the same system evidence has to be produced in two different formats.
- Qualification as a downstream step: compressed construction schedules tempt teams to push CQV activities to the end of the construction phase. When the engineering milestones are reached, the documentation is incomplete, the deviation log is uncontrolled and the regulatory inspection is weeks away.
- Inspection-readiness gaps: incomplete qualification packages, open deviations without CAPA and missing risk assessments take facilities into a Pre-Approval Inspection (PAI) with no buffer.
Services
How we support you
Qualification Master Plan & Strategy
We develop the QMP, align all trades to a shared qualification framework and define acceptance criteria before equipment is ordered. Deliverable: QMP with complete qualification scope, responsibility matrix and decision logic for all GMP-critical systems and utilities.
Parallel Qualification & Construction (IQ/OQ/PQ)
CQV activities are synchronised with the construction schedule. FATs, SATs, IQs and OQs are planned, executed and completed without building up a documentation backlog. Deliverable: a continuously updated qualification package that is complete when construction finishes.
Deviation and CAPA Management
We maintain a live deviation register across all trades, classify every deviation by regulatory impact and close CAPAs before the inspection. Deliverable: a complete audit trail for EU and FDA inspectors with no open critical findings at handover.
Inspection Readiness & PAI Support
We conduct mock inspections, close documentation gaps and prepare the internal team for the authority inspection. Entourage is on site for the actual Pre-Approval Inspection. Deliverable: a complete inspection package and a qualified team for the PAI.
Learn more →How we work together
What it comes down to
A CQV programme (Commissioning, Qualification and Validation) is not a verification block at the end of a construction project, but a parallel process stream that begins with the engineering design and ends with product release. The decisive difference lies in qualification planning before the first sod is turned: anyone who defines acceptance criteria after the equipment has already been ordered is performing a documentation exercise, not a robust qualification. EU GMP Annex 15 and the ISPE Baseline Guide for Commissioning and Qualification set the framework within which CQV activities are linked to the project plan.
The critical bottleneck is the interface between FAT/SAT and IQ/OQ. A Factory Acceptance Test documented in isolation as a supplier acceptance is, at best, wasted qualification work. Anyone who designs FAT protocols from the outset so that they are directly usable as an IQ basis eliminates redundant tests, avoids inconsistencies between acceptance documentation and the qualification package, and completes the first system qualification at the very moment the equipment is commissioned.
The second most common failure pattern lies in deviation management: when the general contractor, the utility supplier and the process equipment supplier keep deviations in separate lists, there is no consolidated audit trail. A Pre-Approval Inspection (PAI) assesses not only the deviation itself, but the evidence that all findings were known, risk-assessed and either closed or held in a CAPA with a traceable timeline. A shared deviation register across all trades is not an optional structural measure, but a prerequisite for this picture to be presented completely and without gaps in an inspection.
Our approach
Our approach
Step
Result
Design & Commissioning Phase
P&IDs, URS and FAT/SAT protocols reviewed within the engineering design. Qualification requirements captured before equipment is ordered. Commissioning documented in a format that is directly usable as an IQ basis.
Qualification Phase (IQ/OQ/PQ)
Installation, operational and performance qualifications executed, or reviewed and approved as a delegated QA function. Risk-based qualification scope: every GMP-critical system qualified to the required depth, not over-qualified where unnecessary.
Validation & First Batch Release
Process validation, cleaning validation and media fills executed in the qualified facility. Complete validation summary report and inspection package prepared. Project team supported through the regulatory inspection up to the first commercial product release.
Common pitfalls
Where projects commonly fail
Qualification only starts once construction is finished.
By then the documentation backlog has already accumulated, the inspection deadline is approaching and every open deviation becomes an escalation. EU GMP Annex 15 explicitly links qualification activities to project planning, not to a downstream event.
FAT and SAT are not designed as an IQ basis.
Anyone who accepts FAT records in a proprietary supplier format and then builds a separate IQ tests the same system state twice. This costs time, creates inconsistencies and is read by FDA inspectors as a sign of poor planning.
No shared deviation register across all trades.
When the general contractor, the utility supplier and the process equipment supplier each keep deviations in their own lists, there is no consolidated audit trail and no reliable overall picture of all critical findings before the PAI.
PQ and process validation are not synchronised.
Anyone who completes performance qualification without having aligned the process validation plan risks that parameters which prove critical in process validation were not sufficiently challenged in the PQ.
Design changes without change control.
Changes to the originally qualified design without a formal change-control procedure invalidate already completed IQ/OQ documentation, which is often only noticed when the inspection is imminent.
FAQ
Frequently asked questions
Sources
- EU GMP Annex 15: Qualification and Validation (EudraLex Vol. 4, revised version)
- EU GMP Annex 1: Manufacture of Sterile Medicinal Products (Revision 2022)
- FDA Guidance for Industry: Process Validation: General Principles and Practices (January 2011)
- ICH Q10: Pharmaceutical Quality System
- ISPE Baseline Guide: Commissioning and Qualification (2nd Edition)
- PIC/S PI 006-3: Recommendations on Validation Master Plan, IQ, OQ
- ASTM E2500: Standard Guide for Specification, Installation and Qualification
- Entourage, cqv.theentourage.de (original source, as of March 2026)
Life Science Journal
Regulatory updates, straight to your inbox.
New requirements, authority decisions and practice notes. Once a month, unsubscribe any time.
Case Studies
What this looks like in practice
Related insights
All insights →Regulations & standards considered
- EU GMP Annex 15 (Qualification and Validation, EudraLex Vol. 4)
- EU GMP Annex 1 (Manufacture of Sterile Medicinal Products, Revision 2022)
- EU GMP Guide Part I, Chapter 4 (Documentation) and Chapter 5 (Production)
- 21 CFR Part 211 (cGMP for Finished Pharmaceuticals)
- FDA Guidance for Industry: Process Validation: General Principles and Practices (January 2011)
- ICH Q10 (Pharmaceutical Quality System)
- ISPE Baseline Guide: Commissioning and Qualification (2nd Edition)
- ASTM E2500: Standard Guide for Specification, Installation and Qualification of Pharmaceutical Production Equipment
- PIC/S PI 006-3: Recommendations on Validation Master Plan, Installation and Operational Qualification
Related topics
Inspection Readiness →
Preparation for authority inspections and Pre-Approval Inspections
Cleanroom Qualification →
Qualification of cleanrooms and controlled environments per ISO 14644
Annex 1 (Sterile Manufacturing) →
Requirements of the revised Annex 1 for sterile manufacturers and HVAC qualification
CAPA Management →
Deviation and CAPA systems for GMP environments
Have a concrete project?
Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.
Prefer direct? +49 89 4161170-0
info@theentourage.de
- Reply usually within one working day
- 4 offices: DE · CH · IT · US
- 100% life sciences